Sabine. L. van Elsland

Sabine. L. van Elsland

Auto-generated profile, based on publicly available information

Sabine. L. van Elsland

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Science
Verified
Journal Article
Open access
PDF file
Mélodie MonodMélodie Monod
Mélodie Monod
ABAlexandra Blenkinsop
Alexandra Blenkinsop
XXXiaoyue Xi
Xiaoyue Xi
DHDaniel Hebert
Daniel Hebert
SBSivan Bershan
Sivan Bershan
OROliver Ratmann
Oliver Ratmann
Age-specific contact: How can the resurgent epidemics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during 2020 be explained? Are they a result of students going back to school? To address this question, Monod et al. created a contact matrix for infection based on data collected in Europe and China and extended it to the United States. Early in the pandemic, before interventions were widely implemented, contacts concentrated among individuals of similar age were the highest among school-aged children, between children and their parents, and between middle-aged adults and the elderly. However, with the advent of nonpharmaceutical interventions, these contact patterns changed substantially. By mid-August 2020, although schools reopening facilitated transmission, the resurgence in the United States was largely driven by adults 20 to 49 years of age. Thus, working adults who need to support themselves and their families have fueled the resurging epidemics in the United States. Science , this issue p. eabe8372

1 June 2011 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
CTC.B. Terwee
C.B. Terwee
WBW. Bouwmeester
W. Bouwmeester
SES.L. van Elsland
S.L. van Elsland
HVH.C.W. de Vet
H.C.W. de Vet
JDJ. Dekker
J. Dekker

2 April 2020 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
NINatsuko Imai
Natsuko Imai
KGKaty A.M. Gaythorpe
Katy A.M. Gaythorpe
SASam Abbott
Sam Abbott
SBSangeeta Bhatia
Sangeeta Bhatia
SESabine van Elsland
Sabine van Elsland
NFNeil M. Ferguson
Neil M. Ferguson
Background: Several non-pharmaceutical interventions (NPIs) have been implemented across the world to control the coronavirus disease (COVID-19) pandemic. Social distancing (SD) interventions applied so far have included school closures, remote working and quarantine. These measures have been shown to have large impacts on pandemic influenza transmission. However, there has been comparatively little examination of such measures for COVID-19. Methods: We examined the existing literature, and collated data, on implementation of NPIs to examine their effects on the COVID-19 pandemic so far. Data on NPIs were collected from official government websites as well as from media sources. Results: Measures such as travel restrictions have been implemented in multiple countries and appears to have slowed the geographic spread of COVID-19 and reduced initial case numbers. We find that, due to the relatively sparse information on the differences with and without interventions, it is difficult to quantitatively assess the efficacy of many interventions. Similarly, whilst the comparison to other pandemic diseases such as influenza can be helpful, there are key differences that could affect the efficacy of similar NPIs. Conclusions: The timely implementation of control measures is key to their success and must strike a balance between early enough application to reduce the peak of the epidemic and ensuring that they can be feasibly maintained for an appropriate duration. Such measures can have large societal impacts and they need to be appropriately justified to the population. As the pandemic of COVID-19 progresses, quantifying the impact of interventions will be a vital consideration for the appropriate use of mitigation strategies.

1 March 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
HSHendrik Simon Schaaf
Hendrik Simon Schaaf
JLJacoba A. Bcomm Laubscher
Jacoba A. Bcomm Laubscher
SESabine L. Msc van Elsland
Sabine L. Msc van Elsland
PDPeter R. Donald
Peter R. Donald
JSJohan F. Schoeman
Johan F. Schoeman
Background: The World Health Organization recommends 12-month treatment (2RHZE/10RH) for children with tuberculous meningitis (TBM). Studies evaluating length of antituberculous treatment for TBM report similar completion and relapse rates comparing 6-month treatment with 12-month treatment. Methods: A prospective evaluation to determine whether short-course intensified treatment (6 RHZEth for HIV-infected and 9RHZEth for HIV-infected) is sufficient and safe in children with drug-susceptible TBM. Results: Of 184 children with TBM, median age 58 months and 90 (49%) male, 98 children (53%) presented at stage II TBM, 64 (35%) at stage III TBM and only 22 (12%) at stage I TBM. Ninety (49%) children were treated at home after the first month of therapy; all others received their full treatment in hospital. The HIV prevalence was 14% (22/155 children tested). Anti-TB drug-induced hepatotoxicity occurred in 5% (8 of 143 children tested), all tested negative for viral hepatitis; in all 8 cases, the original regimen was restarted without recurrence. After treatment completion, 147 (80%) children had a good outcome, 7 (3.8%) died. There was no difference in outcome between HIV-infected and HIV-uninfected children who completed treatment (P = 0.986) nor between TBM-hydrocephalic children who were medically treated or shunted (P = 0.166). Conclusion: Short intensified treatment is safe and effective in both HIV-infected and HIV-uninfected children with drug-susceptible TBM.

25 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NMNatalie V. S. Vinkeles Melchers
Natalie V. S. Vinkeles Melchers
SESabine L. van Elsland
Sabine L. van Elsland
JLJoep M. A. Lange
Joep M. A. Lange
MBMartien W. Borgdorff
Martien W. Borgdorff
JHJan van Den Hombergh
Jan van Den Hombergh
Prisoners are at high risk of developing tuberculosis (TB), causing morbidity and mortality. Prison facilities encounter many challenges in TB screening procedures and TB control. This review explores screening practices for detection of TB and describes limitations of TB control in prison facilities worldwide. A systematic search of online databases (e.g., PubMed and Embase) and conference abstracts was carried out. Research papers describing screening and diagnostic practices among prisoners were included. A total of 52 articles met the inclusion criteria. A meta-analysis of TB prevalence in prison facilities by screening and diagnostic tools was performed. The most common screening tool was symptom questionnaires (63·5%), mostly reporting presence of cough. Microscopy of sputum with Ziehl-Neelsen staining and solid culture were the most frequently combined diagnostic methods (21·2%). Chest X-ray and tuberculin skin tests were used by 73·1% and 50%, respectively, as either a screening and/or diagnostic tool. Median TB prevalence among prisoners of all included studies was 1,913 cases of TB per 100,000 prisoners (interquartile range [IQR]: 332–3,517). The overall annual median TB incidence was 7·0 cases per 1000 person-years (IQR: 2·7–30·0). Major limitations for successful TB control were inaccuracy of diagnostic algorithms and the lack of adequate laboratory facilities reported by 61·5% of studies. The most frequent recommendation for improving TB control and case detection was to increase screening frequency (73·1%). TB screening algorithms differ by income area and should be adapted to local contexts. In order to control TB, prison facilities must improve laboratory capacity and frequent use of effective screening and diagnostic tools. Sustainable political will and funding are critical to achieve this.

1 October 2020 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
KAKylie E. C. Ainslie
Kylie E. C. Ainslie
CWCaroline E. Walters
Caroline E. Walters
HFHan Fu
Han Fu
SBSangeeta Bhatia
Sangeeta Bhatia
HWHaowei Wang
Haowei Wang
SRSteven Riley
Steven Riley
Background : The COVID-19 epidemic was declared a Global Pandemic by WHO on 11 March 2020. By 24 March 2020, over 440,000 cases and almost 20,000 deaths had been reported worldwide. In response to the fast-growing epidemic, which began in the Chinese city of Wuhan, Hubei, China imposed strict social distancing in Wuhan on 23 January 2020 followed closely by similar measures in other provinces. These interventions have impacted economic productivity in China, and the ability of the Chinese economy to resume without restarting the epidemic was not clear. Methods : Using daily reported cases from mainland China and Hong Kong SAR, we estimated transmissibility over time and compared it to daily within-city movement, as a proxy for economic activity. Results : Initially, within-city movement and transmission were very strongly correlated in the five mainland provinces most affected by the epidemic and Beijing. However, that correlation decreased rapidly after the initial sharp fall in transmissibility. In general, towards the end of the study period, the correlation was no longer apparent, despite substantial increases in within-city movement. A similar analysis for Hong Kong shows that intermediate levels of local activity were maintained while avoiding a large outbreak. At the very end of the study period, when China began to experience the re-introduction of a small number of cases from Europe and the United States, there is an apparent up-tick in transmission. Conclusions: Although these results do not preclude future substantial increases in incidence, they suggest that after very intense social distancing (which resulted in containment), China successfully exited its lockdown to some degree. Elsewhere, movement data are being used as proxies for economic activity to assess the impact of interventions. The results presented here illustrate how the eventual decorrelation between transmission and movement is likely a key feature of successful COVID-19 exit strategies.